CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Ixazomib-Thalidomide-Low Dose Dexamethasone (ITd) Induction Followed By Maintenance Therapy with Ixazomib or Placebo in Newly Diagnosed Multiple Myeloma Patients Not Eligible for Autologous Stem Cell Transplantation; Results from the Randomized Phase II HOVON-126/Nmsg 21#13 Trial
Author
Abildgaard Niels
Axelsson Per
+19Â more
Do Trung Hieu
Hansson Markus
Haukas Einar
Klein Saskia K.
Knut-Bojanovska Dorota
Leijs Maria B. L.
Levin Mark-David
Poddighe Pino
Schjesvold Fredrik H.
Sonneveld Pieter
Stege Claudia A. M.
Stevens-Kroef Marian
Svirskaite Asta
Szatkowski Damian L.
van de Donk Niels W. C. J.
van der Holt Bronno
van der Spek Ellen
Waage Anders
Zweegman Sonja
Publication venue
'American Society of Hematology'
Publication date
01/11/2018
Field of study
No full text
VBN